Side Effects of Drugs Annual

Side Effects of Drugs Annual

A Worldwide Yearly Survey of New Data in Adverse Drug Reactions

1st Edition - November 18, 2011

Write a review

  • Editor: Jeffrey Aronson
  • eBook ISBN: 9780444537423

Purchase options

Purchase options
DRM-free (Mobi, EPub, PDF)
Sales tax will be calculated at check-out

Institutional Subscription

Free Global Shipping
No minimum order

Description

The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then as a yearly update to the voluminous encyclopedia, Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of adverse drug reactions and interactions. An international team of specialists has contributed to the informative Annual by critically interpreting it and by pointing to whatever is misleading.

Key Features

  • Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of adverse drug reactions and interactions
  • An international team of specialists has contributed to the informative Annual by critically interpreting it and by pointing to whatever is misleading

Readership

Pharmacologists, clinicians, pharmaceutical companies, clinical toxicologists, clinical pharmacologists and medical libraries

Table of Contents

  • Contributors

    Special reviews

    Cumulative indexes of special reviews, Annuals 11–32

    1 Index of drugs

    2 Index of adverse reactions

    Table of Essays, Annuals 1–32

    Mechanistic and clinical descriptions of adverse drug reactions

    1 EIDOS

    2 DoTS

    How to use this book

    The scope of the Side Effects of Drugs Annuals

    Period covered

    Selection of material

    Classification of drugs

    Names of drugs and chemicals

    System of tagging references

    Indexes

    Abbreviations

    Side Effects Of Drugs Essay

    Three generations

    Renewed concern

    Profiling the risk

    A fourth generation?

    The defenders

    The view today

    Conclusions

    Chapter 1: Central nervous system stimulants and drugs that suppress appetite

    Amphetamines [SED-15, 180; SEDA-30, 1; SEDA-31, 1; SEDA-32, 1]

    Methylxanthines

    Drugs that suppress appetite [SEDA-30, 7; SEDA-31, 9; SEDA-32, 16]

    Drugs used in Alzheimer’s disease [SEDA-30, 8; SEDA-31, 10; SEDA-32, 19]

    Chapter 2: Antidepressant drugs

    General

    Monoamine oxidase inhibitors [SED-15, 2371; SEDA-32, 32]

    Selective serotonin re-uptake inhibitors (SSRIs) [SED-15, 3109; SEDA-30, 16; SEDA-31, 18; SEDA-32, 33]

    Serotonin and noradrenaline re-uptake inhibitors (SNRIs)

    Other antidepressants

    Chapter 3: Lithium

    Chapter 4: Drugs of abuse

    Cannabinoids [SED-15, 614; SEDA-30, 31; SEDA-31, 33; SEDA-32, 55]

    Cocaine [SED-15, 848; SEDA-30, 31; SEDA-31, 37; SEDA-32, 58]

    Opioid analgesics

    Chapter 5: Hypnosedatives and anxiolytics

    Azaspirones [SEDA-28, 52; SEDA-32, 75]

    Benzodiazepines [SED-15, 429; SEDA-30, 49; SEDA-31, 57; SEDA-32, 75]

    Benzodiazepine-like drugs

    Benzodiazepine antagonists

    Other hypnosedatives

    Chapter 6: Antipsychotic drugs

    General [SED-15, 2438; SEDA-32, 83]

    Individual drugs

    Chapter 7: Antiepileptic drugs

    General

    Chapter 8: Opioid analgesics and narcotic antagonists

    General

    Opioid receptor agonists

    Partial opioid receptor agonists

    Opioid receptor antagonists

    Chapter 9: Anti-inflammatory and antipyretic analgesics and drugs used in gout

    Amidopyrine and related compounds

    Aniline derivatives [SED-15, 2679; SEDA-30, 129]

    Anthranilic acid derivatives

    Arylalkanoic acid derivatives [SED-15, 2555; SEDA-31, 186; SEDA-32, 229]

    COX-2 selective inhibitors [SEDA-30, 130; SEDA-31, 190; SEDA-32, 232]

    Indoleacetic acids [SEDA-25, 134]

    Oxicams [SEDA-15, 2555; SEDA-28, 128; SEDA-30, 132; SEDA-32, 233]

    Pyrazolone derivatives (phenylbutazone and related compounds) [SEDA-27, 111]

    Salicylates [SED-15, 15; SEDA-30, 128]

    Miscellaneous drugs

    Drugs used in the treatment of gout

    Chapter 10: General anesthetics and therapeutic gases

    Anesthetic vapors [SEDA-30, 137; SEDA-31, 217; SEDA-32, 243]

    Other vapors

    Intravenous agents: non-barbiturate anesthetics

    Intravenous agents: barbiturate anesthetics

    Chapter 11: Local anesthetics

    General

    Effects related to modes of use [SED-15, 2121; SEDA-30, 152; SEDA-31, 233; SEDA-32, 262]

    Caudal, epidural, and spinal anesthesia

    Individual compounds

    Chapter 12: Neuromuscular blocking agents and skeletal muscle relaxants

    Depolarizing neuromuscular blocking agents

    Non-depolarizing neuromuscular blocking agents [SED-15, 2489; SEDA-31, 248; SEDA-32, 274]

    Skeletal muscle relaxants

    Chapter 13: Drugs that affect autonomic functions or the extrapyramidal system

    Drugs that stimulate both alpha- and beta-adrenoceptors [SEDA-30, 170; SEDA-31, 259; SEDA-32, 281]

    Drugs that predominantly stimulate alpha1-adrenoceptors [SEDA-27, 147; SEDA-30, 172; SEDA-31, 264; SEDA-32, 283]

    Drugs that stimulate beta1-adrenoceptors [SEDA-30, 173; SEDA-31, 265; SEDA-32, 284]

    Drugs that stimulate beta2-adrenoceptors

    Other drugs that increase dopamine activity

    Drugs that affect the cholinergic system [SEDA-30, 177; SEDA-31, 272; SEDA-32, 290]

    Chapter 14: Dermatological drugs, topical agents, and cosmetics

    Cosmetics

    Dermal fillers

    Dyestuffs [SEDA-15, 1573; SEDA-30, 182; SEDA-31, 288; SEDA-32, 296]

    Fragrances

    Phototherapy and photochemotherapy [SED-15, 2823; SEDA-32, 297]

    Vitamin A (retinoids) [SED-15, 3653; SEDA-30, 185; SEDA-32, 298; for vitamin A carotenoids see Chapter 34]

    Vitamin D analogues, topical [SED-15, 594; SEDA-31, 293; SEDA-32, 301; for oral Vitamin D analogues see Chapter 34]

    Chapter 15: Antihistamines (H1 receptor antagonists)

    Chapter 16: Drugs that act on the respiratory tract

    Inhaled glucocorticoids [SEDA-30, 193; SEDA-31, 305; SEDA-32, 311]

    Beta2-adrenoceptor agonists [SEDA-30, 198; SEDA-31, 308; SEDA-32, 314]

    Anticholinergic drugs [SEDA-30, 203; SEDA-31, 311; SEDA-32, 318]

    Leukotriene modifiers [SEDA-30, 203; SEDA-31, 312; SEDA-32, 319]

    Phosphodiesterase type IV inhibitors [SEDA-29, 174; SEDA-30, 203; SEDA-31, 313; SEDA-32, 321]

    Lipoxygenase inhibitors

    Mucolytics [SEDA-32, 325]

    Chapter 17: Positive inotropic drugs and drugs used in dysrhythmias

    Cardiac glycosides [SED-15, 648; SEDA-30, 209; SEDA-31, 321; SEDA-32, 333]

    Other positive inotropic drugs [SED-15, 2822; SEDA-30, 212; SEDA-31, 323; SEDA-32, 336]

    Antidysrhythmic drugs

    Chapter 18: Beta-adrenoceptor antagonists and antianginal drugs

    Beta-adrenoceptor antagonists [SED-15, 452; SEDA-30, 223; SEDA-31, 339; SEDA-32, 363]

    Potassium channel activators

    Nitrates, organic [SEDA-15, 2529; SEDA-30, 225; SEDA-32, 366]

    Calcium channel blockers [SED-15, 598; SEDA-30, 225; SEDA-31, 340; SEDA-32, 366]

    Chapter 19: Drugs acting on the cerebral and peripheral circulations

    Drugs used in the treatment of arterial disorders of the brain and limbs

    Drugs used in the treatment of migraine

    Other peripheral vasodilators

    Chapter 20: Antihypertensive drugs

    Angiotensin converting enzyme inhibitors [SED-15, 226; SEDA-30, 234; SEDA-31, 350; SEDA-32, 379]

    Angiotensin ii receptor antagonists [SED-15, 223; SEDA-30, 238; SEDA-31, 358; SEDA-32, 387]

    Direct renin inhibitors [SEDA-30, 242; SEDA-31, 360; SEDA-32, 000]

    Endothelin receptor antagonists [SED-15, 1215; SEDA-30, 245; SEDA-31, 360; SEDA-32, 389]

    Drugs that act on the sympathetic nervous system [SEDA-30, 245; SEDA-31, 362; SEDA-32, 391]

    Postsynaptic α-adrenoceptor antagonists [SEDA-30, 246; SEDA-31, 363; SEDA-32, 391]

    Imidazoline receptor agonists

    Other centrally acting drugs

    Direct vasodilators

    Chapter 21: Diuretics

    Carbonic anhydrase inhibitors [SED-15, 643; SEDA-30, 254; SEDA-31, 371; SEDA-32, 403]

    Thiazide and thiazide-like diuretics [SED-15, 3375; SEDA-30, 256; SEDA-31, 372; SEDA-32, 405]

    Loop diuretics [SED-15, 567, 1454; SEDA-30, 258; SEDA-31, 375; SEDA-32, 408]

    Aldosterone receptor antagonists

    Osmotic diuretics

    Chapter 22: Metals

    Chapter 23: Metal antagonists

    Iron chelators

    Penicillamine and related drugs [SED-15, 2729; SEDA-30, 274; SEDA-31, 403; SEDA-32, 430]

    Other chelators

    Polystyrene sulfonates [SED-15, 2894; SEDA-30, 275; SEDA-32, 433]

    Chapter 24: Antiseptic drugs and disinfectants

    Aldehydes [SED-15, 1439, 1513; SEDA-31, 409; SEDA-32, 437]

    Bisbiguanides

    Cationic surfactants

    Dyestuffs

    Halogens

    Iodophors [SEDA-15, 1896; SEDA-30, 279; SEDA-31, 411; SEDA-32, 440]

    Phenolic compounds [SED-15, 2800, SEDA-32, 441]

    Chapter 25: Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines

    Beta-lactam antibiotics [SED-15, 478; SEDA-30, 280; SEDA-31, 420; SEDA-32, 447]

    Cephalosporins [SED-15, 688; SEDA-30, 284; SEDA-31, 422; SEDA-32, 448]

    Monobactams and monocarbams [SED-15, 2378; SEDA-30, 286; SEDA-31, 423; SEDA-32, 450]

    Penicillins [SED-15, 2756; SEDA-30, 286; SEDA-31, 424; SEDA-32, 450]

    Tetracyclines and glycylcyclines [SED-15, 3330; SEDA-30, 288; SEDA-31, 419; SEDA-32, 451]

    Chapter 26: Miscellaneous antibacterial drugs

    Aminoglycoside antibiotics [SED-15, 118; SEDA-30, 297; SEDA-31, 427; SEDA-32, 461]

    Chloramphenicol and related drugs [SED-15, 706; SEDA-30, 298; SEDA-31, 429; SEDA-32, 464]

    Fluoroquinolones [SED-15, 1396; SEDA-30, 298; SEDA-31, 429; SEDA-32, 464]

    Glycopeptides [SEDA-30, 435; SEDA-32, 469]

    Ketolides [SED-15, 1976; SEDA-30, 301; SEDA-31, 436; SEDA-32, 471]

    Lincosamides [SED-15, 2063; SEDA-30, 302; SEDA-31, 437; SEDA-32, 472]

    Macrolide antibiotics [SED-15, 2183; SEDA-30, 302; SEDA-31, 437; SEDA-32, 472]

    Nitrofurantoin [SED-15, 2542; SEDA-30, 303; SEDA-31, 439; SEDA-32, 476]

    Oxazolidinones [SED-15, 2645; SEDA-30, 304; SEDA-31, 439]

    Polymyxins [SED-15, 2891; SEDA-31, 441; SEDA-32, 476]

    Streptogramins [SED-15, 3182; SEDA-28, 285; SEDA-30, 307; SEDA-31, 442]

    Sulfonamides, trimethoprim, and co-trimoxazole [SED-15, 3216, 3510; SEDA-30, 308; SEDA-31, 442; SEDA-32, 477]

    Other antimicrobial drugs

    Chapter 27: Antifungal drugs

    Allylamines [SEDA-30, 316; SEDA-31, 457; SEDA-32, 491]

    Amphotericin [SED-15, 192; SEDA-30, 317; SEDA-31, 458; SEDA-32, 493]

    Antifungal azoles [SED-15, 301; SEDA-30, 320; SEDA-31, 459; SEDA-32, 497]

    Echinocandins [SED-15, 1197; SEDA-30, 329; SEDA-31, 464; SEDA-32, 507]

    Flucytosine [SED-15, 1388; SEDA-32, 497]

    Chapter 28: Antiprotozoal drugs

    Antimalarial drugs

    4-Aminoquinolines (chloroquine and congeners) [SEDA-30, 336; SEDA-31, 469; SEDA-32, 521]

    Primaquine and congeners [SED-15, 2919]

    Pyrimethamine and congeners [SED-15, 2984; SEDA-32, 523]

    Quinine and congeners [SED-15, 3002; SEDA-31, 472; SEDA-32, 524]

    Endoperoxides [SED-15, 342; SEDA-30, 338; SEDA-31, 473; SEDA-32, 525]

    Drugs used in the treatment of Pneumocystis jirovecii infections

    Drugs used in the treatment of other protozoal infections

    Miscellaneous drugs

    Chapter 29: Antiviral drugs

    Editor’s notes: Interferons are covered inChapter 37.

    Drugs active against cytomegalovirus

    Drugs active against herpesviruses [SEDA-29, 301; SEDA-30, 343; SEDA-31, 478; SEDA-32, 530]

    Drugs active against hepatitis viruses

    Drugs active against human immunodeficiency virus

    Drugs active against human immunodeficiency virus: combinations

    Drugs active against human immunodeficiency virus: nucleoside analogue reverse transcriptase inhibitors (NRTI) [SED-15, 2586; SEDA-30, 349; SEDA-31, 482; SEDA-32, 534]

    Drugs active against human immunodeficiency virus: nucleotide analogue reverse transcriptase inhibitors

    Drugs active against human immunodeficiency virus: non-nucleoside reverse transcriptase inhibitors (NNRTI) [SED-15, 2553; SEDA-30, 349; SEDA-31, 486; SEDA-32, 537]

    Drugs active against human immunodeficiency virus: protease inhibitors [SED-15, 2586; SEDA-30, 351; SEDA-31, 487; SEDA-32, 541]

    Drugs active against human immunodeficiency virus: inhibitors of HIV fusion [SEDA-28, 337; SEDA-29, 310]

    Drugs active against human immunodeficiency virus: integrase inhibitors

    Drugs active against human immunodeficiency virus: chemokine receptor CCR5 antagonists

    Drugs active against influenza viruses: neuraminidase inhibitors [SED-15, 2436; SEDA-30, 352; SEDA-31, 489; SEDA-32, 544]

    Drugs active against influenza viruses: ion channel inhibitors [SED-15, 105, 3051; SEDA-31, 489; SEDA-32, 544]

    Chapter 30: Drugs used in tuberculosis and leprosy

    Rifamycins [SED-15, 3040; SEDA-30, 359; SEDA-31, 498; SEDA-32, 563]

    Chapter 31: Antihelminthic drugs

    Benzimidazoles [SED-15, 424; SEDA-30, 364; SEDA-31, 508; SEDA-32, 572]

    Chapter 32: Vaccines

    General

    Bacterial vaccines

    Viral vaccines

    Other components of vaccines

    Chapter 33: Blood, blood components, plasma, and plasma products

    Albumin and Derivatives [SED-15, 54; SEDA-30, 381; SEDA-31, 527; SEDA-32, 591]

    Anticoagulant proteins [SED-15, 266; SEDA-30, 381; SEDA-31, 527; SEDA-32, 591]

    Blood transfusion [SED-15, 529; SEDA-30, 381; SEDA-31, 528; SEDA-32, 593]

    Blood substitutes [SEDA-30, 383; SEDA-31, 531; SEDA-32, 593]

    Plasma and plasma products [SED-15, 2847; SEDA-30, 383; SEDA-31, 532; SEDA-32, 594]

    Plasma substitutes [SEDA-30, 384; SEDA-31, 533; SEDA-32, 594]

    Globulins

    Coagulation proteins [SED-15, 845; SEDA-30, 387; SEDA-31, 537; SEDA-32, 596]

    Erythropoietin and derivatives [SED-15, 1243; SEDA-30, 388; SEDA-31, 538; SEDA-32, 597]

    Stem cells [SEDA-30, 389; SEDA-31, 539; SEDA-32, 599]

    Chapter 34: Vitamins, intravenous solutions, and drugs and formulations used in nutrition

    Vitamin A (carotenoids) [SED-15, 3642; SEDA-31, 548; SEDA-32, 607]

    Vitamins of the B group [SED-15, 2700; SEDA-31, 548; SEDA-32, 608]

    Vitamin C (ascorbic acid) [SED-15, 351; SEDA-30, 394; SEDA-31, 548; SEDA-32, 611]

    Vitamin D analogues [SED-15, 3669; SEDA-30, 394; SEDA-31, 549; SEDA-32, 612]

    Vitamin E (tocopherol) [SED-15, 3677; SEDA-30, 395; SEDA-31, 549; SEDA-32, 612]

    Parenteral nutrition [SED-15, 2700; SEDA-31, 549; SEDA-32, 613]

    Enteral nutrition [SED-15, 1221; SEDA-30, 396]

    Chapter 35: Drugs that affect blood coagulation, fibrinolysis, and hemostasis

    Coumarin anticoagulants [SED-15, 983; SEDA-30, 399; SEDA-31, 553; SEDA-32, 617]

    Heparins [SED-15, 1590; SEDA-30, 404; SEDA-31, 556; SEDA-32, 626]

    Direct thrombin inhibitors [SED-15, 1142; SEDA-30, 409; SEDA-31, 559; SEDA-32, 632]

    Indirect factor Xa inhibitors [SEDA-30, 412; SEDA-31, 563; SEDA-32, 636]

    Drugs that alter platelet function [SEDA-30, 413; SEDA-31. 564; SEDA-32, 637]

    Thienopyridines [SED-15, 821; SEDA-30, 415; SEDA-31, 566; SEDA-32, 639]

    Hemostatic agents

    Chapter 36: Gastrointestinal drugs

    Antacids [SED-15, 243; SEDA-30, 423; SEDA-31, 573; SEDA-32, 665]

    Antiemetics and drugs that affect gastrointestinal motility [SEDA-30, 423; SEDA-31, 573; SEDA-32, 665]

    5HT3 receptor antagonists [SED-15, 1365; SEDA-30, 423; SEDA-31, 575; SEDA-32, 666]

    Neurokinin NK1 receptor antagonists [SEDA-32, 667]

    Histamine H2 receptor antagonists [SED-15, 1629; SEDA-30, 423; SEDA-31, 576; SEDA-32, 667]

    Helicobacter pylori eradication regimens [SED-15, 1586; SEDA-30, 425; SEDA-31, 579]

    Proton pump inhibitors [SED-15, 2973; SEDA-30, 424; SEDA-31, 577; SEDA-32, 667]

    Other ulcer-healing agents

    Laxatives and oral bowel preparations [SED-15, 2008; SEDA-30, 426; SEDA-31, 581; SEDA-32, 668]

    Aminosalicylates [SED-15, 138; SEDA-30, 428; SEDA-31, 583; SEDA-32, 669]

    Antispasmodic agents

    Antidiarrheal agents

    Cholelitholytic agents, bile acids

    Other gastrointestinal agents

    Chapter 37: Drugs that act on the immune system

    Colony-stimulating factors [SEDA-30, 435; SEDA-31, 589; SEDA-32, 675]

    Interferons [SED-15, 1841; SEDA-30, 436; SEDA-31, 591; SEDA-32, 676]

    Interleukins [SED-15, 1831; SEDA-30, 438; SEDA-31, 592; SEDA-32, 676]

    Tumor necrosis factor alfa (TNF-α) and its antagonists [SEDA-30, 439; SEDA-31, 592; SEDA-32, 677]

    Monoclonal antibodies [SED-15, 2380; SEDA-30, 442; SEDA-31, 602; SEDA-32, 686]

    Chapter 38: Drugs that act on the immune system

    Thiopurines

    Chapter 39: Corticotrophins, corticosteroids, and prostaglandins

    Systemic glucocorticoids [SED-15, 906; SEDA 30, 463; SEDA-31, 651; SEDA-32, 723]

    Prostaglandins and analogues [SED-15, 2955; SEDA-30, 465; SEDA-31, 651; SEDA-32, 729]

    Chapter 40: Sex hormones and related compounds, including hormonal contraceptives

    Gonadotropins [SED-15, 1536; SEDA-30, 468; SEDA-31, 656; SEDA-32, 735]

    Estrogens [SED-15, 1253; SEDA-30, 469; SEDA-31, 657; SEDA-32, 736]

    Hormonal contraceptives [SED-15, 1642; SEDA-30, 473; SEDA-31, 663; SEDA-32, 741]

    Antiestrogens and selective estrogen receptor modulators (SERMs) [SEDA-30, 474; SEDA-31, 664; SEDA-32, 743]

    Progestogens [SED-15, 2930; SEDA-30, 477; SEDA-31, 669; SEDA-32, 747]

    Progesterone antagonists [SEDA-30, 477; SEDA-31, 671; SEDA-32, 749]

    Sex hormone agonists

    Sex hormone antagonists

    Anabolic steroids, androgens, and related compounds [SED-15, 216; SEDA-30, 477; SEDA-31, 672; SEDA-32, 751]

    Antiandrogens [SEDA-29, 510; SEDA-30, 479; SEDA-31, 673; SEDA-32, 755]

    Chapter 41: Thyroid hormones, iodine, and antithyroid drugs

    Thyroid hormones [SED-15, 3409; SEDA-30, 490; SEDA-31, 687; SEDA-32, 763]

    Iodine and iodides [SED-15, 1896; SEDA-30, 490; SEDA-31, 688; SEDA-32, 764]

    Antithyroid drugs [SEDA-15, 3387; SEDA-30, 490; SEDA-31, 689; SEDA-32, 765]

    Chapter 42: Insulin, other hypoglycemic drugs, and glucagon

    Glucagon [SED-15, 1510; SEDA-31, 689; SEDA-32, 769]

    Insulin [SED-15, 1761; SEDA-30, 494; SEDA-31, 689; SEDA-32, 769]

    Alpha-glucosidase inhibitors [SED-15, 85; SEDA-30, 496; SEDA-31, 691; SEDA-32, 772]

    Amylin analogues [SEDA-30, 496; SEDA-31, 692; SEDA-32, 773]

    Biguanides [SED-15, 506; SEDA-30, 497; SEDA-31, 692; SEDA-32, 773]

    Dipeptidyl peptidase 4 (DDP-4) inhibitors [SEDA-30, 498; SEDA-31, 693; SEDA-32, 774]

    Incretin mimetics [SEDA-30, 49; SEDA-31, 695; SEDA-32, 775]

    Meglitinides [SED-15, 2238; SEDA-31, 695; SEDA-32, 776]

    Sodium glucose transporter type 2 (SGLT2) inhibitors

    Sulfonylureas [SED-15, 3230; SEDA-30, 500; SEDA-31, 695; SEDA-32, 777]

    Thiazolidinediones (glitazones) [SED-15, 3380; SEDA-30, 501; SEDA-31, 697; SEDA-32, 779]

    Peroxisome proliferator-activated dual receptor agonists [SEDA-32, 782]

    Chapter 43: Miscellaneous hormones

    Vasopressin receptor antagonists

    Vasopressin and analogues [SED-15, 3609; SEDA-30, 511; SEDA-31, 710; SEDA-32, 798]

    Chapter 44: Drugs that affect lipid metabolism

    Nicotinic acid derivatives [SED-15, 2512; SEDA-32, 815]

    Chapter 45: Cytostatic and cytotoxic drugs

    Other cytotoxic drugs

    Chapter 46: Radiological contrast agents and radiopharmaceuticals

    MRI contrast media

    Ultrasound contrast agents [SED-15, 3543; SEDA-30, 540; SEDA-32, 855]

    Thorotrast [SED-15, 3401; SEDA-28, 565]

    Radiopharmaceuticals [SED-15, 3017]

    Chapter 47: Drugs used in ocular treatment

    Drugs used in the management of age-related macular degeneration [SEDA-30, 545; SEDA-31, 739; SEDA-32, 865]

    Adrenoceptor agonists [SEDA-31, 740; SEDA-32, 869]

    Anti-glaucoma drugs

    Beta-adrenoceptor antagonists [SEDA-31, 740; SEDA-32, 870]

    Carbonic anhydrase inhibitors

    Glucocorticosteroids [SED-15, 906; SEDA-30, 548; SEDA-31, 741; SEDA-32, 871]

    Prostaglandin analogues (see also Chapter 39) [SEDA-32, 871]

    Procedures

    Chapter 48: Treatments used in complementary and alternative medicine

    Asian herbal medicines [SED-15, 1609; SEDA-32, 879]

    Injectable formulations of chinese medicines

    Indian Medicines

    Specific plants

    Animal drugs

    Acupuncture

    Chiropractic

    Skin branding

    Spa therapy

    Chapter 49: Miscellaneous drugs, materials, medical devices, and techniques

    Dyestuffs

    Index of drugs

    Index

Product details

  • No. of pages: 1160
  • Language: English
  • Copyright: © Elsevier 2011
  • Published: November 18, 2011
  • Imprint: Elsevier
  • eBook ISBN: 9780444537423

About the Editor

Jeffrey Aronson

Affiliations and Expertise

Reader in Clinical Pharmacology

Ratings and Reviews

Write a review

There are currently no reviews for "Side Effects of Drugs Annual"